Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
International Journal of Urology : Official Journal of the Japanese Urological Association|June 17, 2025
Preliminary Report on the Efficacy and Safety of Triplet Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer: YUSHIMA StudyYosuke Yasuda, Noboru Numao, Shunya Matsumoto, et al.
Japanese Journal of Clinical Oncology|May 12, 2026
Adverse impact of bladder biopsy on the rate of intravesical recurrences following radical nephroureterectomy for upper tract urothelial carcinomaTomonori Kanagawa, Ichiro Yonese, Takehiro Nakamura, et al.
Hinyokika Kiyo. Acta Urologica Japonica|May 20, 2004
[A case bilharziasis in a Japanese male]Sachi Kitayama, Nobuhiko Hyochi, Toshiki Kijima, et al.
Diagnostics (Basel, Switzerland)|December 24, 2021
Prognostic Accuracy of the qSOFA Score for In-Hospital Mortality in Elderly Patients with Obstructive Acute Pyelonephritis: A Multi-Institutional StudyYudai Ishikawa, Hiroshi Fukushima, Hajime Tanaka, et al.
Clinical Genitourinary Cancer|September 21, 2025
Impact of Impaired Renal Function on the Efficacy and Safety of Enfortumab Vedotin Monotherapy in a Multicenter Real-World Cohort of Patients With Metastatic Urothelial Cancer: YUSHIMA StudyHiroshi Fukushima, Yuki Nakamura, Hajime Tanaka, et al.
Clinical Genitourinary Cancer|January 28, 2025
Enfortumab Vedotin for Metastatic Urothelial Carcinoma: Comprehensive Treatment Outcomes and Prognostic Insights From a Multicenter Real-World Study (YUSHIMA Study)Yuki Nakamura, Hajime Tanaka, Noboru Numao, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 16, 2024
Outcomes and prognostic factors in patients with synchronous and metachronous oligometastatic urothelial carcinoma with visceral metastasesSoichiro Yoshida, Yuya Maezawa, Kensaku Ishihara, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 11, 2026
Prognostic Significance of Hypoalbuminemia in Maintenance Avelumab Therapy After First-Line Chemotherapy for Metastatic Urothelial Carcinoma: A Multicenter Real-World Study (YUSHIMA Study)Rie Muta, Hiroshi Fukushima, Hajime Tanaka, et al.
International Journal of Clinical Oncology|April 21, 2025
Prognostic factors and effect of existing predictive models in oligo-metastatic urothelial carcinoma (YUSHIMA study)Kenji Tanabe, Soichiro Yoshida, Tomoki Kimura, et al.
International Journal of Clinical Oncology|June 4, 2024
Gustave Roussy Immune score as a prognostic biomarker in patients with platinum-refractory metastatic urothelial carcinoma treated with pembrolizumab: YUSHIMA studyKenji Tanabe, Shuichiro Kobayashi, Yuya Maezawa, et al.
Pageof 6